These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33124149)

  • 1. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
    Mok DZL; Chan CYY; Ooi EE; Chan KR
    FEBS J; 2021 Sep; 288(17):5055-5070. PubMed ID: 33124149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
    Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
    EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
    Lin H; Ma X; Xiao F; Su H; Shi Y; Liu Y; Song L; Zhang Z; Zhang C; Peng H
    FEBS J; 2021 Sep; 288(17):5163-5178. PubMed ID: 34228902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship.
    Oberemok VV; Laikova KV; Yurchenko KA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Jul; 69(7):635-640. PubMed ID: 32350571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
    J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.
    Ferrarini MG; Lal A; Rebollo R; Gruber AJ; Guarracino A; Gonzalez IM; Floyd T; de Oliveira DS; Shanklin J; Beausoleil E; Pusa T; Pickett BE; Aguiar-Pulido V
    Commun Biol; 2021 May; 4(1):590. PubMed ID: 34002013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural basis of accelerated host cell entry by SARS-CoV-2†.
    Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD
    FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.
    Hannan MA; Rahman MA; Rahman MS; Sohag AAM; Dash R; Hossain KS; Farjana M; Uddin MJ
    Immunol Lett; 2020 Oct; 226():38-45. PubMed ID: 32659267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host PDZ-containing proteins targeted by SARS-CoV-2.
    Caillet-Saguy C; Durbesson F; Rezelj VV; Gogl G; Tran QD; Twizere JC; Vignuzzi M; Vincentelli R; Wolff N
    FEBS J; 2021 Sep; 288(17):5148-5162. PubMed ID: 33864728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies.
    Varghese PM; Tsolaki AG; Yasmin H; Shastri A; Ferluga J; Vatish M; Madan T; Kishore U
    Immunobiology; 2020 Nov; 225(6):152008. PubMed ID: 33130519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Characterization of SARS-CoV-2.
    Dërmaku-Sopjani M; Sopjani M
    Curr Mol Med; 2021; 21(7):589-595. PubMed ID: 33272175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Crosstalk With the Hallmarks of Aging.
    Salimi S; Hamlyn JM
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):e34-e41. PubMed ID: 32544216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection.
    Andreakos E; Abel L; Vinh DC; Kaja E; Drolet BA; Zhang Q; O'Farrelly C; Novelli G; Rodríguez-Gallego C; Haerynck F; Prando C; Pujol A; ; Su HC; Casanova JL; Spaan AN
    Nat Immunol; 2022 Feb; 23(2):159-164. PubMed ID: 34667308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peripheral and core regions of virus-host network of COVID-19.
    Wang B; Dong X; Hu J; Ma X; Han C; Wang Y; Gao L
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33956950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of whey protein on viral infection and replication of SARS-CoV-2 and pangolin coronavirus in vitro.
    Fan H; Hong B; Luo Y; Peng Q; Wang L; Jin X; Chen Y; Hu Y; Shi Y; Li T; Zhuang H; Zhou YH; Tong Y; Xiang K
    Signal Transduct Target Ther; 2020 Nov; 5(1):275. PubMed ID: 33235188
    [No Abstract]   [Full Text] [Related]  

  • 20. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.